Immunological dysregulation in polyendocrine metabolic ovarian syndrome: from immune-metabolic crosstalk to biomarkers and targeted therapies
Year: 2026
Type: article
Abstract: Polyendocrine metabolic ovarian syndrome (PMOS), formerly termed polycystic ovary syndrome (PCOS), encompasses heterogeneous reproductive and metabolic phenotypes. Immune dysregulation may amplify endocrine–metabolic dysfunction, but its direction, anatomical distribution, and causal importance remain uncertain. This narrative Mini Review integrates human observational evidence with animal and cell-based experiments and critically examines the implications for biomarkers and treatment. Human studies support altered nutrient-responsive inflammatory signaling and associations between adipose dysfunction, insulin resistance, and immune activation. However, ovarian findings cannot be reduced to generalized hyperinflammation: recent single-cell profiling suggests disruption of coordinated ovulatory immune communication alongside chronic inflammatory and extracellular-matrix programs. Experimental studies implicate macrophage–granulosa-cell interactions, androgen-sensitive inflammasome regulation, and the microbiota–bile acid–interleukin-22 axis, but these results establish mechanisms within particular models rather than causality in women. Interpretation is constrained by small or selected cohorts, inconsistent participant reporting, adiposity and treatment confounding, stimulated ovarian sampling, and limited external validation. Recent probiotic trials also illustrate the distinction between changes in surrogate markers and reproducible clinical benefit. No immune signature discussed here has sufficient evidence for routine diagnostic or treatment-selection use. Progress requires transparent population reporting, donor-level analyses, longitudinal and tissue-resolved studies, independent biomarker validation, and trials that prioritize reproductive and metabolic outcomes over isolated cytokine changes.
Source: Frontiers in Immunology
Authors: Wei-Ting Lee(Conceptualization, Data curation, Investigation, Methodology, Software, Validation, Visualization, Writing – original draft, Writing – review & editing), Cherry Yin-Yi Chang(Data curation, Investigation, Supervision, Writing – original draft), Hsun-Ming Chang(Conceptualization, Funding acquisition, Methodology, Project administration, Supervision, Visualization, Writing – original draft, Writing – review & editing)
Institutions: China Medical University Hospital, China Medical University
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Keywords: polyendocrine metabolic ovarian syndrome, polycystic ovary syndrome, immune dysregulation, immune-metabolic crosstalk, biomarkers, targeted therapy, insulin resistance, adipose tissue dysfunction, ovarian inflammation, inflammasome, gut microbiota, bile acids, IL-22, probiotics, single-cell profiling, ovulation
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7233860604
